363 results on '"MOORE, MARTIN L."'
Search Results
2. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
3. Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy
4. Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy
5. Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
6. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy
7. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice
8. Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery
9. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease
10. Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells
11. Respiratory Syncytial Virus and Reactive Airway Disease
12. Influence of Respiratory Syncytial Virus Strain Differences on Pathogenesis and Immunity
13. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma
14. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins
15. Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling
16. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors
17. Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing
18. An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
19. The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses
20. Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection
21. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis
22. BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV)
23. ERRATUM: Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
24. Independent Structural Domains in Paramyxovirus Polymerase Protein
25. Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
26. Reverse Genetics of Respiratory Syncytial Virus
27. Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk
28. RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice.
29. Early infection with repiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma
30. Toward Primary Prevention of Asthma. Reviewing the Evidence for Early-Life Respiratory Viral Infections as Modifiable Risk Factors to Prevent Childhood Asthma
31. Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease
32. One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
33. The intersection of respiratory syncytial virus infection, innate immunity and allergic lung disease
34. IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse
35. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics
36. Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think
37. Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial Virus
38. A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion
39. The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen
40. A Mechanistic Advance in Understanding RSV Pathogenesis, but Still a Long Way from Therapy
41. Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus–induced type 2 responses and immunopathology
42. An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
43. Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles
44. Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design
45. Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform
46. The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen.
47. Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze
48. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
49. Polyvalent vaccines: High-maintenance heroes
50. Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.